Cholinergic receptor alterations in the brain stem of spinal cord injured Rats

Neurochemical Research

Volumn 38, Issue 2, 2013, Pages 389-397

  Romeo, Chinthu ^a   Raveendran, Anju Thoppil ^a   Sobha, Nandhu Mohan ^a   Paulose, Cheramadathukuzhiyil Scaria ^a  

^a Department of Physics   (India)

Author keywords

Brain stem; Cholinergic receptors; Grid walk test; Muscarinic; Nicotinic; Spinal cord injury

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINE ACETYLTRANSFERASE; CHOLINERGIC RECEPTOR; METABOTROPIC RECEPTOR; MUSCARINIC M1 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC RECEPTOR; NICOTINIC RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN STEM; BRAIN STEM INJURY; CONTROLLED STUDY; COORDINATION; DOWN REGULATION; GENE EXPRESSION; LOCOMOTION; MALE; MOTONEURON; MOTOR COORDINATION; MOTOR DYSFUNCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SPINAL CORD INJURY; UPREGULATION;

ANIMALS; BRAIN STEM; DOWN-REGULATION; MALE; PROTEIN BINDING; RANDOM ALLOCATION; RATS; RATS, WISTAR; RECEPTOR, MUSCARINIC M1; RECEPTOR, MUSCARINIC M3; RECEPTORS, CHOLINERGIC; RECEPTORS, NICOTINIC; SPINAL CORD INJURIES;

RATTUS;

EID: 84876416417     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-012-0931-x     Document Type: Article

References (61)

1. Grillner S (1981) Control of locomotion in bipeds, tetrapods, and fish. In: Brooks VB (ed) Handbook of physiology. Waverly press, Baltimore, pp 1179-1236
2. Feldman JL, Grillner S (1983) Control of vertebrate respiration and locomotion: a brief account. Physiologist 26:310-316
3. Grillner S (1985) Neurobiological bases of rhythmic motor acts. Science 228:143-149
4. Grillner S, Walln P (1985) Central pattern generators for locomotion, with special reference to vertebrates. Annu Rev Neurosci 8:233-261
5. James K, Wamsley MS, Lewis W, Scott Y, Michael JK (1981) Autoradiographic localization of muscarinic cholinergic receptors in rat brainstem. J Neurosci 1:176-191
6. Marc Z, Eliane T, Daniel B, Mario R (1999) Presence of functional neuronal nicotinic acetylcholine receptors in brainstem motoneurons of the rat. Eur J Neurosci 11:2737-2748
7. Lambert DG, Appadu BL (1995) Muscarinic receptor subtypes: do they have a place in clinical anesthesia? Br J Anaesth 74:74497-74499
8. Durieux ME (1996) Muscarinic signaling in the central nervous system. Recent developments and anesthetic implications. Anesthesiology 84:173-189
9. Gomeza J, Shannon H, Kostenis E, Felder C, Zhang L, Brodkin J, Grinberg A et al (1999) Pronounced pharmacologic deficits in M2 muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci USA 96:1692-1697
10. Nathaniel TI, Umesiri FE, Olajuyigbe F (2008) Role of M1 receptor in the locomotion behaviour of the African mole-rat (Cryptomys sp). J Integr Neurosci 7:1-16
11. Tsuyoshi M, Masahisa Y, Alokesh D, Jurgen W (2001) Hyperactivity and intact hippocampus-dependent learning in mice lacking the M1 muscarinic acetylcholine receptor. J Neurosci 21:5239-5250
12. Mc Bride WJ, Murphy JM, Ikemoto S (1999) Localisation of brain reinforcement mechanisms: intra cranial self administration and intra cranial place conditioning studies. Behav Brain Res 101:129-152
13. Sziraki I, Sershen S, Benuck M, Hashim A, Lajtha A (1998) Receptor systems participating in system specific effects. Neurochem Int 33:445-457
14. Yeomans JS, Kofmana O, McFarlanea V (1985) Cholinergic involvement in lateral hypothalamic rewarding brain stimulation. Brain Res 329:326-339
15. Exley R, Cragg SJ (2008) Presynaptic nicotinic receptors: a dynamic and diverse cholinergic filter of striatal dopamine neurotransmission. Br J Pharmacol 153:S283-S297
16. Livingstone PD, Wonnacott S (2009) Nicotinic acetylcholine receptors and the ascending dopamine pathways. Biochem Pharmacol 78:744-755
17. Menzaghi F, Whelan KT, Risbrough VB, Rao TS, Lloyd GK (1997) Effects of a novelcholinergic ion channel agonist SIB-1765F on locomotor activity in rats. J Pharmacol Exp Ther 280:384-392
18. Pawlak CR (2005) Schwarting RK (2005) Repeated nicotine treatment in rats with high versus low rearing activity: analyses of behavioural sensitisation and place preference. Psychopharmacology 178:440-450
19. Villégier AS, Salomon L, Sylvie Granon, Champtiaux N, Changeux JP, Tassin JP (2010) Behavioral, integrative and clinical neuroscience α7 and β2*nicotinic receptors control monoamine-mediated locomotor response. Neuroreport 21:1085-1089
20. Misawa H, Nakata K, Matsuura J, Nagao M, Okuda T, Haga T (2001) Distribution of the high-affinity choline transporter in the central nervous system of the rat. Neuroscience 105:87-98
21. Kus L, Borys E, Ping Chu Y, Ferguson SM, Blakely RD, Emborg ME, Kordower JH et al (2003) Distribution of high affinity choline transporter immunoreactivity in the primate central nervous system. J Comp Neurol 463:341-357
22. Kuhar MJ, Murrin LC (1978) Sodium-dependent, high affinity choline uptake. J Neurochem 30:15-21
23. Atweh S, Simon JR, Kuhar MJ (1975) Utilization of sodiumdependent high affinity choline uptake in vitro as a measure of the activity of cholinergic neurons in vivo. Life Sci 17:1535-1544
24. Vickroy TW, Roeske WR, Yamamura HI (1984) Sodiumdependent high-affinity binding of [3H]hemicholinium-3 in the rat brain: a potentially selective marker for presynaptic cholinergic sites. Life Sci 35:2335-2343
25. Saltarelli MD, Lowenstein PR, Coyle JT (1987) Rapid in vitro modulation of [3H]hemicholinium-3 binding sites in ratstriatal slices. Eur J Pharmacol 135:35-40
26. Bakhit C, Armanini M, Wong WL, Bennett GL, Wrathall JR (1991) Increase in nerve growth factor-like immunoreactivity and decrease in choline acetyltransferase following contusive spinal cord injury. Brain Res 554:264-271
27. Cummings JL (2000) Cholinesterase inhibitors: a new class of psychotropic compounds. Am J Psychiatry 157:4-15
28. Haroutunian V, Davidson M, Kanof PD, Perl DP, Powchik P, Losonczy M, McCrystal J et al (1994) Cortical cholinergic markers in schizophrenia. Schizophr Res 12:37-144
29. Powchik P, Davidson M, Haroutunian V, Gabriel SM, Purohit DP, Perl DP, Harvey PD et al (1998) Postmortem studies in schizophrenia. Schizophr Bull 24:325-341
30. Mancama D, Arranz MJ, Landau S, Kerwin R (2003) Reduced expression of the muscarinic 1 receptor cortical subtype in schizophrenia. Am J Med Genet 119:2-6
31. Paulose CS, John PS, Sreekanth R, Mathew P, Padmarag MC, Jobin M, Peeyush KT et al (2009) Spinal cord regeneration and functional recovery: neurotransmitter's combination and bone marrow cells supplementation. Curr Sci 97:546-549
32. Glowinski J, Iversen LL (1966) Regional studies of catecholamines in the rat brain. The disposition of [3H] norepinephrine, [3H] dopamine and [3H] dopa in various regions of the brain. J Neurochem 13:655-669
33. Yamamura HI, Synder G (1974) Muscarinic cholinergic binding in rat brain. Proc Natl Acad Sci USA 71:1725-1729
34. Sherin A, Peeyush KT, Naijil G, Nandhu MS, Jes P, Paulose CS (2011) The effects of abnormalities of glucose homeostasis on the expression and binding of muscarinic receptors in cerebral cortex of rats. Eur J Pharmacol 651:128-136
35. Lowry OH, Roserbbrough N, Farr AL, Randall RJ et al (1951) Protein measurement with Folin phenol reagent. J Biol Chem 193:265-275
36. Scatchard G (1949) The attractions of proteins for small molecules and ions. Ann N Y Acad Sci 51:660-672
37. Z'Graggen WJ, Metz GA, Kartje GL, Thallmair M, Schwab ME (1998) Functional recovery and enhanced corticofugal plasticity after unilateral pyramidal tract lesion and blockade of myelin-associated neurite growth inhibitors in adult rats. J Neurosci 18:4744-4757
38. Roy S, Laurent J, Réjean DAlford S (2010) A parallel cholinergic brainstem pathway for enhancing locomotor drive. Nat Neurosci 13:731-738
39. Brown JH, Taylor P (1996) Muscarinic receptor agonists and antagonists. In: Hardman JG, LE Limbird LE, Molinoff PB, Ruddon RW, Gilman AG (eds) Goodman and Gilman's the pharmacological basis of therapeutics, 9th edn edn. McGraw-Hill, New York, pp 141-160
40. Wess J, Buhl T, Lambrecht G, Mutschler E (1990) Cholinergic receptors. In: Emmett JC (ed) Comprehensive medicinal chemistry, Pergamon Press, Oxford, 3, pp 423-491
41. Burgen AS (1995) The background of the muscarinic system. Life Sci 56:801-806
42. Luthin GR, Wang P, Zhou H, Dhanasekaran D, Ruggieri MR (1997) Role of m1 receptor-G protein coupling in cell proliferation in the prostate. Life Sci 60:963-968
43. Zaninetti M, Tribollet E, Bertrand D, Raggenbass M (1999) Presence of functional neuronal nicotinic acetylcholine receptors in brainstem motoneurons of the rat. Eur J Neurosci 11:2737-2748
44. Nakamura M, Fujimura Y, Yato Y, Watanabe M, Yabe Y (1996) Changes in choline acetyltransferase activity and distribution following incomplete cervical spinal cord injury in the rat. Neuroscience 75:481-494
45. Strada O, Sheela V, Etienne CH, Merle R, Alexis B, Yves A, France J (1992) Decreased choline acetyltransferase mRNA expression in the nucleus basalis of Meynert in Alzheimer disease: an in situ hybridization study. Neurobiology Proc Natl Acad Sci USA 89:9549-9553
46. Grimm JW, Chapman MA, Zahm DS, See RE (2001) Decreased choline acetyltransferase immunoreactivity in discrete striatal subregions following chronic haloperidol in rats. Synapse 39:51-57
47. Labombarda F, Gonzalez SL, Gonzalez DM, Guennoun R, Schumacher M, de Nicola AF (2002) Cellular basis for progesterone neuroprotection in the injured spinal cord. J Neurotrauma 19:343-355
48. Massoulie J, Bon S (1982) The molecular forms of cholinesterase and acetylcholinesterase in vertebrates. Annu Rev Neurosci 5:595-605
49. Romero-Vecchione E, Fatranská M, Kvetnanský R (1987) Acetylcholinesterase activity in several hypothalamic and brain stem nuclei after acute and chronic immobilization stress in rats. Endocrinol Exp 21:159-165
50. Jiang H, Zhang J, Zhu H, Li H, Zhang X (2007) Nerve growth factor prevents the apoptosis-associated increase in acetylcholinesterase activity after hydrogen peroxide treatment by activating Akt. Acta Biochim Biophys Sin (Shanghai) 39:46-56
51. Mooradian AD (1988) Effect of aging on the blood-brain barrier. Neurobiol Aging 9:31-39
52. Thouvarecq R, Protais P, Jouen F, Caston J (2001) Influence of cholinergic system on motor learning during aging in mice. Behav Brain Res 118:209-218
53. Bethea JR, Nagashima H, Acosta MC, Briceno C, Gomez F, Marcillo AE, Loor K, Green J, Dietrich WD (1999) Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats. J Neurotrauma 16:851-863
54. Ramon-Cueto A, Cordero MI, Santos-Benito FF, Avila J (2000) Functional recovery of paraplegic rats and motor axon regeneration in their spinal cords by olfactory ensheathing glia. Neuron 25:425-435
55. Kamencic H, Griebel RW, Lyon AW, Paterson PG, Juurlink BH (2001) Promoting glutathione synthesis after spinal cord trauma decreases secondary damage and promotes retention of function. FASEB J 15:243-250
56. Webb AA, Muir GD (2003) Unilateral dorsal column and rubrospinal tract injuries affect overground locomotion in the unrestrained rat. Eur J Neurosci 18:412-422
57. Weaver LC, Verghese P, Bruce JC, Fehlings MG, Krenz NR, Marsh DR (2001) Autonomic dysreflexia and primary afferent sprouting after clip-compression injury of the rat spinal cord. J Neurotrauma 18:1107-1119
58. Hulsebosch CE, Xu GY, Perez-Polo JR, Westlund KN, Taylor CP, McAdoo DJ (2000) Rodent model of chronic central pain after spinal cord contusion injury and effects of gabapentin. J Neurotrauma 17:1205-1217
59. Bruehlmeier M, Dietz V, Leenders KL, Roelcke U, Missimer J, Curt A (1998) How does the human brain deal with a spinal cord injury? Eur J Neurosci 10:3918-3922
60. Calford MB, Tweedale R (1988) Immediate and chronic changes in responses of somatosensory cortex in adult flying-fox after digit amputation. Nature 332:446-448
61. Florence SL, Jain N, Pospichal MW, Beck PD, Sly DL, Kaas JH (1996) Central reorganization of sensory pathways following peripheral nerve regeneration in fetal monkeys. Nature 381:69-71